Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum
Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences: Leerink Global ...
Q1 Earnings Estimate for Vaxcyte Issued By Leerink Partnrs
Research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Vaxcyte in a research report issued to clients and investors on Tuesday, February 25th. Leerink Partnrs ...
Hims & Hers price target raised to $40 from $24 at Leerink
Leerink raised the firm’s price target on Hims & Hers to $40 from $24 and keeps a Market Perform rating on the shares following the Q4 ...
Hosted on MSN11d
Leerink Partners Initiates Coverage of aTyr Pharma (ATYR) with Outperform Recommendation
Fintel reports that on February 18, 2025, Leerink Partners initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a ...
FiercePharma12d
Leerink group goes beyond conventional metrics to evaluate cost-effectiveness of key therapies
Over the last decade, as the Institute for Clinical and Economic Review (ICER) has estimated the cost-effectiveness of newly ...
Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, ...
Leerink raises Genmab stock rating to outperform, PT steady at $27
Leerink Partners analyst shifted the rating for Genmab A/S (NASDAQ:GMAB) stock from Market Perform to Outperform, maintaining a price target (PT) of $27.00. The upgrade reflects a positive long-term ...
Business Wire6d
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway ...
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that ...